Skip to main content
DGX logo
DGX
(NYSE)
Quest Diagnostics Incorporated
$193.75-- (--)
Loading... - Market loading

Quest Diagnostics Incorporated (DGX) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Quest Diagnostics Incorporated
DGXNew York Stock ExchangeHealthcareDiagnostics & Research

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer’s disease; and women’s health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Company Information

CEOJames Davis
Founded1967
IPO DateDecember 17, 1996
Employees57,000
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNew York Stock Exchange (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone973 520 2700
Address
500 Plaza Drive Secaucus, New Jersey 07094 United States

Corporate Identifiers

CIK0001022079
CUSIP74834L100
ISINUS74834L1008
EIN16-1387862
SIC8071

Leadership Team & Key Executives

James E. Davis
Chairman, Chief Executive Officer and President
Sam A. Samad
Executive Vice President and Chief Financial Officer
Michael E. Prevoznik J.D.
Senior Vice President and General Counsel
Catherine T. Doherty
Executive Vice President of Regional Businesses
Karthik Kuppusamy Ph.D.
Senior Vice President of Clinical Solutions
Michael J. Deppe
Senior Vice President, Corporate Controller and Chief Accounting Officer
Murali Balakumar
Senior Vice President and Chief Information and Digital Officer
Dan Haemmerle
Interim Vice President of Investor Relations and VP Finance
Kristin Lee Wallace Esq.
Senior Vice President and Chief Compliance Officer
Garry Clark
Senior Vice President and Chief Marketing and Communications Officer